Site Management/Investigator Payments Featured Articles
-
The Site Landscape Is Evolving, But How? Tufts CSDD Shares New Findings
10/20/2026
Tufts CSDD data reveals how academic, independent, and network-affiliated clinical trial sites differ in growth, reach, staffing, and performance.
-
Your EDC Query Count Is Trying To Tell You Something
10/14/2026
A rising EDC query count may reveal more than dirty data. Learn how query patterns can expose upstream problems in trial workflows, training, and CRF design.
-
What I Heard When I Crashed Three ING Dive Teams
10/13/2026
After attending three Innovation Network Gathering Dive Teams, Chief Editor Dan Schell shares what he heard about accelerating study startup, rethinking investigator meetings, and leading through AI adoption—along with a reminder that promising ideas still need stakeholder support, measurable evidence, and practical execution.
-
5 Sponsor Contracting Issues That Delay Clinical Trials — And How To Avoid Them
10/7/2026
CTA negotiations don’t have to stall study start-up. Learn five sponsor-side contracting issues that cause delays and practical ways to prevent them.
-
Long-Distance Rare Disease Trials: Why PLL Landed On Australia And New Zealand
9/29/2026
Australia and New Zealand had a lot to offer PLL Therapeutics, but speed and savings aren't the only upsides for running its rare disease trial from its European home.
-
The 50-Page Monitoring Report And The Illusion Of Control
9/24/2026
A massive decentralized trial showed why more monitoring doesn’t always mean more control — and how risk-based oversight can reveal what truly matters.
-
The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is Suspect
9/23/2026
Starting site work before an enforceable agreement may look like flexibility, but it can drain leverage, create unrecoverable costs, and raise financial reporting and GCP concerns.
-
How AI Will Reshape Study Start-Up
9/14/2026
AI can help study start-up teams move from tracking delays to predicting risks—if human judgment, data quality, and governance stay central.
-
Why ING Feels Different
9/11/2026
I’ve attended enough clinical trial conferences to know how similar they can feel. ING is different. Its Dive Teams, WhaleTank, and candid conversations are designed to get attendees participating, not just listening. This year, I’m especially interested in an off-the-record regulatory panel that could tackle some of the biggest changes facing clinical research.
-
From An Empty Building To High-Tech Production
9/10/2026
Explore the journey from empty facility to advanced manufacturing hub, covering project execution, team alignment, quality systems, community partnerships, and global expansion.